[U.S. Food and Drug Administration]

FDA PUBLIC CALENDAR

Food and Drug Administration
Office of Public Affairs
5600 Fishers Lane
Rockville, MD 20857

This public calendar is issued by the Food and Drug Administration. It lists meetings held by the FDA policymakers with persons outside the executive branch of the Federal Government.

October 30 - November 5, 1998

FDA Official and Title Date and SiteOther FDA ParticipantsNon-FDA ParticipantsSubject
Dr. Michael A. Friedman, M.D., Acting Commissioner of Food and Drugs 11/6 Rockville, MD Joseph A. Levitt and Fred Shank C.D.Mote, Jr., President; Dean Paul Mazzocchi, Mr. Brian Darmody (University of MD at College Park) JIFSAN & White Oak consolidation (no minutes available)
Diane E. Thompson, Associate Commissioner for Legislative Affairs 10/27 Washington, DC Susan Setterberg, Central Regional Director; James Rahto, District Director Senator Paul Wellstone, Rep. Gil Gutknecht, Rep. Bruce Vento, Members of the Minn. Senior Federation Discuss Drugs Import
Diane E. Thompson, Associate Commissioner for Legislative Affairs 11/2 Washington, DC Dr. Murry Lumpkin, CDER; Dr. Janet Woodcock, Director, CDER Jay Hawkins - Sen. Jeffords Staff, Senator William Frist's Staff, Cong. Tom Bliley's Staff To discuss Adverse Reaction Reporting
Dr. Stuart Nightingale, Assoc. Commissioner for Health Affairs 10/30 Baltimore, MD Brian Malkin Members of the Johns Hopkins University working group on civilian biodefense Draft documents
Dr. Stuart Nightingale, Assoc. Commissioner for Health Affairs 10/30 Baltimore, MD Janet Showalter and others Participants in the Drug Information Association (DIA) workshop "ICH Process" Delivered speech -- "View from a Regulatory Agency"
Dr. Stuart Nightingale, Assoc. Commissioner for Health Affairs 11/2-3 Washington, DC Ellen Morrison, Dr. Leanne Jackson, Dr. Jesse Goodman, Dr. Elaine Esber, Michelle Limoli Members of the institute of Medicine (IOM) Forum on Emerging Infections Workshop - "Public Health Systems: Assessing Capacities to Respond to Emerging Infections" Participated in Workshop
Dr. Kathryn C. Zoon, Ph.D., Director, CBER 11/6 Bethesda, MD AttendeesAttendees at BIO Workshop Status of CBER Initiatives
Dr. Stephen F. Sundlof, Director, Center for Veterinary Medicine 11/4 MPN-2 Dr. Andrew BeaulieuDr. Jay Rash, Dr. Michael McGowan (Pfizer) Drug approval process
Dr. Stephen F. Sundlof, Director, Center for Veterinary Medicine 11/4 MPN-2 Several CVM StaffRep. of the Am. Assoc. of Swine practitioners Veterinary Feed Directives

Return to FDA News Page

November 9, 1998